109 related articles for article (PubMed ID: 10838496)
1. Microsatellite instability in thyroid papillary carcinoma and multinodular hyperplasia.
Dobosz T; Lukienczuk T; Sasiadek M; Kuczyńska A; Jankowska E; Blin N
Oncology; 2000 May; 58(4):305-10. PubMed ID: 10838496
[TBL] [Abstract][Full Text] [Related]
2. Infrequent microsatellite instability in papillary carcinomas of the thyroid.
Yamamoto T
Hiroshima J Med Sci; 1999 Sep; 48(3):95-8. PubMed ID: 10598412
[TBL] [Abstract][Full Text] [Related]
3. [Loss of heterozygosity on chromosome 3p in thyroid tumors].
Hu MJ; Xu HD; Zhou R; Li XF; Zhang HY
Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):305-8. PubMed ID: 18956647
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological Significance of Overall Frequency of Allelic Loss (OFAL) in Lesions Derived from Thyroid Follicular Cell.
Migdalska-Sęk M; Czarnecka KH; Kusiński M; Pastuszak-Lewandoska D; Nawrot E; Kuzdak K; Brzeziańska-Lasota E
Mol Diagn Ther; 2019 Jun; 23(3):369-382. PubMed ID: 30747408
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations in papillary thyroid carcinoma and hashimoto thyroiditis: An analysis of hOGG1 loss of heterozygosity.
Royer MC; Zhang H; Fan CY; Kokoska MS
Arch Otolaryngol Head Neck Surg; 2010 Mar; 136(3):240-2. PubMed ID: 20231640
[TBL] [Abstract][Full Text] [Related]
6. Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses.
Obermann EC; Junker K; Stoehr R; Dietmaier W; Zaak D; Schubert J; Hofstaedter F; Knuechel R; Hartmann A
J Pathol; 2003 Jan; 199(1):50-7. PubMed ID: 12474226
[TBL] [Abstract][Full Text] [Related]
7. Clinico-pathological significance of cell-type-specific loss of heterozygosity on chromosome 7q21: analysis of 318 microdissected thyroid lesions.
Trovato M; Ulivieri A; Dominici R; Ruggeri RM; Vitarelli E; Benvenga S; Barresi G; Trimarchi F; Brunetti E; Vecchione A; Andreoli M; Sciacchitano S
Endocr Relat Cancer; 2004 Jun; 11(2):365-76. PubMed ID: 15163311
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity on chromosome 16p and 18q in anaplastic thyroid carcinoma.
Kadota M; Tamaki Y; Sekimoto M; Fujiwara Y; Aritake N; Hasegawa S; Kobayashi T; Ikeda T; Horii A; Monden M
Oncol Rep; 2003; 10(1):35-8. PubMed ID: 12469141
[TBL] [Abstract][Full Text] [Related]
9. [Microsatellite instability and allele-specific chromosome 3p deletion in breast cancer and precancerous lesions].
Fu Q; Yao GY; Tang XL; Chen LR; Zheng ZX
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):34-40. PubMed ID: 17575691
[TBL] [Abstract][Full Text] [Related]
10. Microsatellite instability and loss of heterozygosity in radiation-associated thyroid carcinomas of Belarussian children and adults.
Richter HE; Lohrer HD; Hieber L; Kellerer AM; Lengfelder E; Bauchinger M
Carcinogenesis; 1999 Dec; 20(12):2247-52. PubMed ID: 10590215
[TBL] [Abstract][Full Text] [Related]
11. MSI and LOH in the development and prognosis of follicular cell-derived thyroid tumours.
Migdalska-Sęk M; Pastuszak-Lewandoska D; Brzeziańska E
Endokrynol Pol; 2012; 63(2):126-36. PubMed ID: 22538752
[TBL] [Abstract][Full Text] [Related]
12. Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas.
Ward LS; Brenta G; Medvedovic M; Fagin JA
J Clin Endocrinol Metab; 1998 Feb; 83(2):525-30. PubMed ID: 9467569
[TBL] [Abstract][Full Text] [Related]
13. Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients.
de Leeuw WJ; Dierssen J; Vasen HF; Wijnen JT; Kenter GG; Meijers-Heijboer H; Brocker-Vriends A; Stormorken A; Moller P; Menko F; Cornelisse CJ; Morreau H
J Pathol; 2000 Nov; 192(3):328-35. PubMed ID: 11054716
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of minisatellite and microsatellite instability in radiation-induced post-Chernobyl pediatric thyroid carcinomas.
Nikiforov YE; Nikiforova M; Fagin JA
Oncogene; 1998 Oct; 17(15):1983-8. PubMed ID: 9788442
[TBL] [Abstract][Full Text] [Related]
15. Screening of selected genomic areas potentially involved in thyroid neoplasms.
Oriola J; Halperin I; Mallofré C; Muntané J; Angel M; Rivera-Fillat F
Eur J Cancer; 2001 Dec; 37(18):2470-4. PubMed ID: 11720845
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity in follicular and papillary thyroid carcinomas.
Rodrigues-Serpa A; Catarino A; Soares J
Cancer Genet Cytogenet; 2003 Feb; 141(1):26-31. PubMed ID: 12581895
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity in 73 human thyroid tumors.
Wozniak A; Wiench M; Olejniczak A; Wloch J; Lachinski A; Lange D; Olczyk T; Jarzab B; Limon J
Neuro Endocrinol Lett; 2005 Oct; 26(5):521-5. PubMed ID: 16264407
[TBL] [Abstract][Full Text] [Related]
18. High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene.
Farrand K; Delahunt B; Wang XL; McIver B; Hay ID; Goellner JR; Eberhardt NL; Grebe SK
J Clin Endocrinol Metab; 2002 Oct; 87(10):4715-21. PubMed ID: 12364463
[TBL] [Abstract][Full Text] [Related]
19. Assessment of microsatellite instability in bladder and thyroid malignancies.
Vaish M; Mishra SK; Mandhani A; Mittal RD; Mittal B
Teratog Carcinog Mutagen; 2003; Suppl 1():255-65. PubMed ID: 12616616
[TBL] [Abstract][Full Text] [Related]
20. Analysis of DNA mismatch repair gene expression and mutations in thyroid tumours.
Ruschenburg I; Vollheim B; Stachura J; Cordon-Cardo C; Korabiowska M
Anticancer Res; 2006; 26(3A):2107-12. PubMed ID: 16827152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]